A chimeric epidermal growth factor with fibrin affinity promotes repair of injured keratinocyte sheets

Acta Biomaterialia

Volumn 5, Issue 7, 2009, Pages 2623-2632

  Kitajima, Takashi ^a,b   Sakuragi, Makoto ^a,b   Hasuda, Hirokazu ^b   Ozu, Takeshi ^b   Ito, Yoshihiro ^a,b  

^a INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

^b KANAGAWA ACADEMY OF SCIENCE AND TECHNOLOGY   (Japan)

Author keywords

Chimeric protein; EGF immobilization; Fibrin; Wound healing

Indexed keywords

CELL CULTURE; GROWTH KINETICS; PROTEINS; TISSUE; TISSUE REGENERATION;

BINDING DOMAIN; BOUND-STATES; CHIMERIC PROTEINS; DOSE-DEPENDENT; EPIDERMAL GROWTH FACTOR IMMOBILIZATION; EPIDERMAL GROWTH FACTORS; FIBRIN; IMMOBILISATION; KERATINOCYTES; WOUND HEALING;

REPAIR;

BINDING PROTEIN; EPIDERMAL GROWTH FACTOR; FIBRIN; FIBRIN BINDING DOMAIN PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL DAMAGE; CELL GROWTH; CELL PROLIFERATION; CELL REGENERATION; CONTROLLED STUDY; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; KERATINOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; WOUND HEALING;

EID: 68949148874     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2009.03.022     Document Type: Article

References (41)

1. Mosesson M.W. Fibrinogen and fibrin structure and functions. J Thromb Haemost 3 (2005) 1894-1904
2. Cohen S. The stimulation of epidermal proliferation by a specific protein (EGF). Dev Biol 12 (1965) 394-407
3. Rheinwald J.G., and Green H. Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes. Nature 265 (1977) 421-424
4. Cohen S., and Carpenter G. Human epidermal growth factor: Isolation and chemical and biological properties. Proc Natl Acad Sci USA 72 (1975) 1317-1321
5. Gospodarowicz D., Brown K.D., Birdwell C.R., and Zetter B. Control of proliferation of human vascular endothelial cells. J Cell Biol 77 (1978) 774-788
6. Buckley A., Davidson J.M., Kamerath C.D., Wolt T.B., and Woodward S.C. Sustained release of epidermal growth factor accelerates wound repair. Proc Natl Acad Sci USA 82 (1985) 7340-7344
7. Jyung R.W., and Mustoe T.A. Role of cytokines in wound repair. In: Oppenheim J.J., Rossio J.L., and Gearing A.J.H. (Eds). Clinical application of cytokines (1993), Oxford University Press, Oxford 307-327
8. Sakiyama-Elbert S.E., Panitch A., and Hubbell J.A. Development of growth factor fusion proteins for cell-triggered drug delivery. FASEB J 13 (2001) 1300-1302
9. Ehrbar M., Djonov V.G., Schnell C., Tschanz S.Z., Martiny-Baron G., Schenk U., et al. Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth. Circ Res 94 (2004) 1124-1132
10. Zisch A.H., Schenk U., Schense J.C., Sakiyama-Elbert S.E., and Hubbell J.A. Covalently conjugated VEGF-fibrin matrices for endothelialization. J Control Release 72 (2001) 101-113
11. Schmoekel H.G., Weber F.E., Schense J.C., Gratz K.W., Schawalder P., and Hubbell J.A. Bone repair with a form of BMP-2 engineered for incorporation into fibrin cell ingrowth matrices. Biotechnol Bioeng 89 (2005) 253-262
12. Sekiguchi K., and Hakomori S.-I. Domain structure of human plasma fibronectin. J Biol Chem 258 (1983) 3967-3973
13. Yamada K.M. Fibronectin domains and receptors. In: Mosher D.F. (Ed). Biology of extracellular matrix: series A. Fibronectin (1989), Academic Press, San Diego, CA 47-121
14. Kawase Y., Ohdate Y., Shimojo T., Taguchi Y., Kimizuka F., and Kato I. Construction and characterization of a fusion protein with epidermal growth factor and the cell-binding domain of fibronectin. FEBS Lett 298 (1992) 126-128
15. Ishikawa T., Terai H., and Kitajima T. Production of a biologically active epidermal growth factor fusion protein with high collagen affinity. J Biochem 129 (2001) 627-633
16. Kitajima T., Terai H., and Ito Y. A fusion protein of hepatocyte growth factor for immobilization to collagen. Biomaterials 28 (2007) 1989-1997
17. 2-terminal fibrin-binding site of fibronectin is formed by interacting fourth and fifth finger domains. Studies with recombinant finger fragments expressed in Escherichia coli. J Biol Chem 269 (1994) 9539-9546
18. 2-terminal fibrin-binding site on fibronectin. J Biol Chem 269 (1994) 31938-31945
19. Rostagno A.A., Schwarzbauer J.E., and Gold L.I. Comparison of the fibrin-binding activities in the N- and C-termini of fibronectin. Biochem J 338 (1999) 375-386
20. Ito Y., Hasuda H., Sakuragi M., and Tsuzuki S. Surface modification of plastic, glass and titanium by photoimmobilization of polyethylene glycol for antibiofouling. Acta Biomater 3 (2007) 1024-1032
21. Ura H., Takeda F., and Okochi H. An in vitro outgrowth culture system for normal human keratinocytes. J Dermatol Sci 35 (2004) 19-28
22. Bradshaw G.L., and Dubes G.R. Supplementary factors required for serum-free culture of rat kidney cells of line NRK-49F. In Vitro 19 (1983) 735-742
23. Barrandon Y., and Green H. Cell migration is essential for sustained growth of keratinocyte colonies: the roles of transforming growth factor-alpha and epidermal growth factor. Cell 50 (1987) 1131-1137
24. Geer D.J., and Andreadis S.T. A novel role of fibrin in epidermal healing: plasminogen-mediated migration and selective detachment of differentiated keratinocytes. J Invest Dermatol 121 (2003) 1210-1216
25. Rybarczyk B.J., Lawrence S.O., and Simpson-Haidaris P.J. Matrix-fibrinogen enhances wound closure by increasing both cell proliferation and migration. Blood 102 (2003) 4035-4043
26. Ito Y. Covalently immobilized biosignal molecule materials for tissue engineering. Soft Matter 4 (2008) 46-56
27. Sharon J.L., and Puleo D.L. The use of N-terminal immobilization of PTH(1-34) on PLGA to enhance bioactivity. Biomaterials 29 (2008) 3137-3142
28. Wall S.T., Saha K., Ashton R.S., Kam K.R., Schaffer D.V., and Healy K.E. Multivalency of sonic hedgehog conjugated to linear polymer chains modulates protein potency. Bioconjug Chem 19 (2008) 806-812
29. Elloumi I., Kobayashi R., Funabashi H., Mie M., and Kobatake E. Construction of epidermal growth factor fusion protein with cell adhesive activity. Biomaterials 27 (2006) 3451-3458
30. Nishi N., Matsushita O., Yuube K., Miyanaka H., Okabe A., and Wada F. Collagen-binding growth factors: production and characterization of functional fusion proteins having a collagen-binding domain. Proc Natl Acad Sci USA 95 (1998) 7018-7023
31. Hall F.L., Kaiser A., Liu L., Chen Z.H., Hu J., Nimni M.E., et al. Design, expression, and renaturation of a lesion-targeted recombinant epidermal growth factor-von Willebrand factor fusion protein: efficacy in an animal model of experimental colitis. Int J Mol Med 6 (2000) 635-643
32. Ishikawa T., Terai H., Yamamoto K., Harada K., and Kitajima T. Delivery of a growth factor fusion protein having collagen-binding activity to wound tissues. Artif Organs 27 (2003) 147-154
33. Hollier B., Harkin D.G., Leavesley D., and Upton Z. Responses of keratinocytes to substrate-bound vitronectin: growth factor complexes. Exp Cell Res 305 (2005) 221-232 Erratum in: Exp Cell Res 308:236-40
34. Hollier B.G., Kricker J.A., Van Lonkhuyzen D.R., Leavesley D.I., and Upton Z. Substrate-bound insulin-like growth factor (IGF)-I-IGF binding protein-vitronectin-stimulated breast cell migration is enhanced by coactivation of the phosphatidylinositide 3-kinase/AKT pathway by v-integrins and the IGF-I receptor. Endocrinology 149 (2008) 1075-1090
35. Upton Z., Cuttle L., Noble A., Kempf M., Topping G., Malda J., et al. Vitronectin: growth factor complexes hold potential as a wound therapy approach. J Invest Dermatol 128 (2008) 1535-1544
36. Liu H., Collins S.F., and Suggs L.J. Three-dimensional culture for expansion and differentiation of mouse embryonic stem cells. Biomaterials 27 (2006) 6004-6014
37. Willerth S.M., Arendas K.J., Gottlieb D.I., and Sakiyama-Elbert S.E. Optimization of fibrin scaffolds for differentiation of murine embryonic stem cells into neural lineage cells. Biomaterials 27 (2006) 5990-6003
38. Itabashi Y., Miyoshi S., Kawaguchi H., Yuasa S., Tanimoto K., Furuta A., et al. A new method for manufacturing cardiac cell sheets using fibrin-coated dishes and its electrophysiological studies by optical mapping. Artif Organs 29 (2005) 95-103
39. Beattie G.M., Montgomery A.M., Lopez A.D., Hao E., Perez B., Just M.L., et al. A novel approach to increase human islet cell mass while preserving beta-cell function. Diabetes 51 (2002) 3435-3439
40. Bensaïd W., Triffitt J.T., Blanchat C., Oudina K., Sedel L., and Petite H. A biodegradable fibrin scaffold for mesenchymal stem cell transplantation. Biomaterials 24 (2003) 2497-2502
41. Mol A., van Lieshout M.I., Dam-de Veen C.G., Neuenschwander S., Hoerstrup S.P., Baaijens F.P., et al. Fibrin as a cell carrier in cardiovascular tissue engineering applications. Biomaterials 26 (2005) 3113-3121